Phenomic AI Companies
Phenomic AI uses artificial intelligence to analyze phenotypes in complex disease models, including high-content co-culture and 3D assays, to discover and optimize therapeutics directly against phenotypic assays. The company's drug discovery platform makes it easier for pharmaceutical companies to discover drugs.
Investors
Total Funding:
11391214.0
Headquarters:
Toronto, Ontario, Canada
Funding Status:
Seed
Employee Number:
5
Estimated Revenue:
$6 million
Last Funding Type:
Seed
Technology:
Artificial Intelligence, Biotechnology, Information Technology, Machine Learning
Last Funding Date:
2020-10-07
Investors Number:
13.0
Founded Date:
2017-01-01
Industry:
BioTech & Health Care